Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant melanoma.

Filippo de Braud1, David Khayat, Bin B R Kroon

  • 1START Project, European Institute of Oncology, Milan, Italy. start@cancerworld.org

Critical Reviews in Oncology/Hematology
|July 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Advances in the Management of Typical and Atypical Lung Carcinoids.

Clinical lung cancer·2021
Same author

Anticancer innovative therapy congress: Highlights from the 10th anniversary edition.

Cytokine & growth factor reviews·2021
Same author

Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.

Journal for immunotherapy of cancer·2021
Same author

Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.

TH open : companion journal to thrombosis and haemostasis·2021
Same author

Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index.

Journal of gastrointestinal cancer·2021
Same author

A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.

Molecular oncology·2021
Same journal

Neoadjuvant Immunotherapy in Melanoma: From Pathologic Response to Response-Adapted Management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: implications for tumor biology and therapeutic strategies - a comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long Non-Coding RNAs in Triple-Negative Breast Cancer: Emerging Drivers of Tumor Biology, Prognosis, and Drug Resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
Same journal

Gene Fusions in Non-small cell lung carcinoma (NSCLC): Expert Perspectives and Practical Considerations for routine testing.

Critical reviews in oncology/hematology·2026
Same journal

Opportunities and Challenges of Dihydrodiol dehydrogenase Expression in Hepatocellular carcinoma.

Critical reviews in oncology/hematology·2026
See all related articles

Cutaneous melanoma incidence is rising rapidly in Europe. Early detection using the ABCDE scheme and understanding risk factors like sun exposure are crucial for melanoma prognosis and treatment.

Area of Science:

  • Dermatology
  • Oncology
  • Public Health

Background:

  • Cutaneous melanoma incidence is increasing in the European Community, representing 1-1.8% of cancers in men and women.
  • Major risk factors include sun exposure, patient phenotype, family history, and prior melanoma.
  • Changes in skin lesions over months are key indicators of melanoma development.

Purpose of the Study:

  • To review the epidemiology, risk factors, early detection, staging, and treatment of cutaneous melanoma.
  • To highlight the importance of early diagnosis and prognostic factors.
  • To discuss current and emerging treatment modalities.

Main Methods:

  • Review of epidemiological data and risk factors for cutaneous melanoma.
  • Discussion of the ABCDE early detection scheme.

Related Experiment Videos

  • Overview of current staging (pre-AJCC/UICC 2002 manual) and treatment strategies.

    • Main Results:

    • Melanoma incidence is rising faster than other cancers.
    • Tumour stage at diagnosis is the primary prognostic factor.
    • Surgery is standard for operable disease; chemotherapy and radiation have roles in advanced cases.

    Conclusions:

    • Early detection and accurate staging are critical for melanoma patient outcomes.
    • Sentinel node biopsy shows promise for detecting lymph node metastasis.
    • Further research on follow-up frequency is needed.